BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:The Future of Personalized Medicine - Stefan Harrer - IBM Research
DTSTART:20140923T130000Z
DTEND:20140923T140000Z
UID:TALK54109@talks.cam.ac.uk
CONTACT:Jerome Charmet
DESCRIPTION:DNA-sequencing approaches the 1000-Dollar-Genome milestone all
 owing for decoding a complete human genome with unmatched speed and at low
  cost. Increased sequencing efficiency yields massive amounts of genomic d
 ata. Analysis of this data eventually enables understanding the role of ea
 ch DNA segment and its correlation with the risk of developing a certain d
 isease. New drug targets are identified and validated continuously and can
  be matched with a personalized genetic risk assessment. Access to this in
 formation triggers fundamental questions for doctors and patients alike: W
 hat are the chances of an outbreak? Are drugs available? What is the best 
 combination of prevention and treatment? In order to provide answers\, tec
 hnologies for discovering novel drugs\, for improving existing drugs and f
 or their intelligent use in an increasingly complex environment\, will hav
 e to be revolutionized. The path from fast and cheap personalized sequenci
 ng via genomics big data analysis towards personal prevention and treatmen
 t will reshape medicine as we know it. IBM Research works at the forefront
  of this process: we develop bionanosensor chips for next-generation DNA-s
 equencing and drug discovery\, and we employ supercomputers for life scien
 ces research\, genomics analysis and smarter healthcare. We strive to re-i
 nvent personalized medicine\, the next big thing emerging from marrying na
 notechnology\, biotechnology and the power of big data. In this talk I wil
 l describe IBM’s engagement in biospace research with a special focus on
  two of our bionanotechnology flagship projects: (I) IBM’s “DNA Transi
 stor”\, a 4 th -generation nanopore-based DNA-sequencing chip\, and (II)
  the Bionanotechnology Research Program” of IBM Research Australia which
  aims at developing novel ways for drug discovery and screening.
LOCATION:Kapitza Building\, MRC Seminar Room\, Cavendish Laboratory\, Depa
 rtment of Physics
END:VEVENT
END:VCALENDAR